Adherex Technologies (FENC) Competitors $8.65 -0.01 (-0.12%) Closing price 04:00 PM EasternExtended Trading$8.64 -0.01 (-0.06%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FENC vs. IOVA, SION, TRVI, URGN, CRON, IMNM, QURE, PGEN, AKBA, and AVXLShould you be buying Adherex Technologies stock or one of its competitors? The main competitors of Adherex Technologies include Iovance Biotherapeutics (IOVA), Sionna Therapeutics (SION), Trevi Therapeutics (TRVI), Urogen Pharma (URGN), Cronos Group (CRON), Immunome (IMNM), uniQure (QURE), Precigen (PGEN), Akebia Therapeutics (AKBA), and Anavex Life Sciences (AVXL). These companies are all part of the "pharmaceutical products" industry. Adherex Technologies vs. Its Competitors Iovance Biotherapeutics Sionna Therapeutics Trevi Therapeutics Urogen Pharma Cronos Group Immunome uniQure Precigen Akebia Therapeutics Anavex Life Sciences Iovance Biotherapeutics (NASDAQ:IOVA) and Adherex Technologies (NASDAQ:FENC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment. Which has higher valuation and earnings, IOVA or FENC? Adherex Technologies has lower revenue, but higher earnings than Iovance Biotherapeutics. Adherex Technologies is trading at a lower price-to-earnings ratio than Iovance Biotherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIovance Biotherapeutics$164.07M5.58-$372.18M-$1.23-2.06Adherex Technologies$47.54M5.06-$440K-$0.42-20.60 Does the media favor IOVA or FENC? In the previous week, Iovance Biotherapeutics had 2 more articles in the media than Adherex Technologies. MarketBeat recorded 20 mentions for Iovance Biotherapeutics and 18 mentions for Adherex Technologies. Iovance Biotherapeutics' average media sentiment score of 0.81 beat Adherex Technologies' score of -0.18 indicating that Iovance Biotherapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Iovance Biotherapeutics 9 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Adherex Technologies 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Is IOVA or FENC more profitable? Adherex Technologies has a net margin of -35.05% compared to Iovance Biotherapeutics' net margin of -161.44%. Adherex Technologies' return on equity of 0.00% beat Iovance Biotherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Iovance Biotherapeutics-161.44% -52.87% -41.31% Adherex Technologies -35.05%N/A -23.92% Which has more risk & volatility, IOVA or FENC? Iovance Biotherapeutics has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Comparatively, Adherex Technologies has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500. Do analysts recommend IOVA or FENC? Iovance Biotherapeutics presently has a consensus target price of $11.90, suggesting a potential upside of 370.36%. Adherex Technologies has a consensus target price of $13.33, suggesting a potential upside of 54.14%. Given Iovance Biotherapeutics' higher probable upside, research analysts clearly believe Iovance Biotherapeutics is more favorable than Adherex Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Iovance Biotherapeutics 1 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.36Adherex Technologies 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do institutionals and insiders hold more shares of IOVA or FENC? 77.0% of Iovance Biotherapeutics shares are owned by institutional investors. Comparatively, 55.5% of Adherex Technologies shares are owned by institutional investors. 10.3% of Iovance Biotherapeutics shares are owned by insiders. Comparatively, 11.0% of Adherex Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryIovance Biotherapeutics and Adherex Technologies tied by winning 8 of the 16 factors compared between the two stocks. Get Adherex Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for FENC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FENC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FENC vs. The Competition Export to ExcelMetricAdherex TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$240.87M$3.06B$5.76B$9.72BDividend YieldN/A2.24%4.40%4.10%P/E RatioN/A20.9030.1925.84Price / Sales5.06390.30474.98187.82Price / Cash268.1543.2325.7828.79Price / Book-41.199.649.425.99Net Income-$440K-$54.08M$3.27B$265.29M7 Day Performance5.49%2.62%2.05%2.53%1 Month Performance0.23%4.05%3.58%0.92%1 Year Performance51.75%9.48%30.09%18.70% Adherex Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FENCAdherex Technologies1.9173 of 5 stars$8.65-0.1%$13.33+54.1%+51.9%$240.87M$47.54M0.0010News CoverageAnalyst RevisionIOVAIovance Biotherapeutics4.6015 of 5 stars$2.50-2.0%$11.90+376.0%-77.3%$922.73M$241.53M-2.03500News CoverageGap DownSIONSionna TherapeuticsN/A$21.39+2.7%$38.50+80.0%N/A$918.99MN/A0.0035News CoverageHigh Trading VolumeTRVITrevi Therapeutics2.8678 of 5 stars$7.45-0.9%$20.38+173.5%+152.5%$915.76MN/A-17.7420URGNUrogen Pharma4.5255 of 5 stars$19.40-1.6%$31.43+62.0%+37.3%$911.87M$90.40M-5.84200CRONCronos Group0.3931 of 5 stars$2.53+6.8%N/A+11.1%$907.80M$117.61M50.60450IMNMImmunome1.6082 of 5 stars$10.25-0.3%$23.14+125.8%-33.3%$894.82M$9.04M-3.3340News CoverageAnalyst ForecastQUREuniQure2.4319 of 5 stars$15.66-3.2%$37.45+139.2%+153.6%$887.75M$14.34M-3.99500News CoveragePGENPrecigen3.8466 of 5 stars$2.95+0.3%$6.00+103.4%+260.3%$876.04M$3.92M-7.02190AKBAAkebia Therapeutics3.9069 of 5 stars$3.11-4.3%$6.75+117.0%+108.5%$861.72M$203.73M-18.29430Analyst RevisionAVXLAnavex Life Sciences3.7408 of 5 stars$9.59-3.5%$44.00+358.8%+50.8%$854.21MN/A-16.8240Analyst Forecast Related Companies and Tools Related Companies Iovance Biotherapeutics Alternatives Sionna Therapeutics Alternatives Trevi Therapeutics Alternatives Urogen Pharma Alternatives Cronos Group Alternatives Immunome Alternatives uniQure Alternatives Precigen Alternatives Akebia Therapeutics Alternatives Anavex Life Sciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FENC) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adherex Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adherex Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access